RecruitingPhase 2 / Phase 3NCT05431088
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sponsor: Pfizer
New Brunswick, NJ · +43 more sites
2 recruiting sickle cell disease studies with a site in New Brunswick, NJ.
All trials in New Brunswick, NJ · All Sickle Cell Disease trials
Sponsor: Pfizer
New Brunswick, NJ · +43 more sites
Sponsor: Sanofi
New Brunswick, NJ · +4 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.